AstraZeneca Pharma India informs about change in senior management

01 Aug 2023 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, AstraZeneca Pharma India has informed about the change in role of Atul Tandon, Business Unit Head – Oncology. He will be transitioning from the said role with effect from close of business hours on July 31, 2023, as he takes up another responsibility within AstraZeneca group. In the interim, the Oncology Business Unit of the Company will be managed by Ayush Kumar Agarwal, who is currently the Director - Commercial Excellence.

The above information is a of company’s filings submitted to BSE. 

Astrazeneca Pharma I Share Price

9031.85 123.15 (1.38%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×